18670280

Source:http://linkedlifedata.com/resource/pubmed/id/18670280

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0005684, umls-concept:C0013556, umls-concept:C0086388, umls-concept:C1521761
pubmed:issue	5
pubmed:dateCreated	2008-8-1
pubmed:abstractText	The diagnosis and treatment of bladder cancer represents a significant financial burden to the population in the United States. Therapeutic advances in bladder cancer care have come at a high cost to payers, providers, and patients. This study describes the principals of cost-effectiveness evaluation in healthcare and provides recommendations for a more economical use of resources in bladder cancer care.
pubmed:grant	http://linkedlifedata.com/resource/pubmed/grant/1 UL1 RR024160-01
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/9200621
pubmed:citationSubset	IM
pubmed:status	MEDLINE
pubmed:month	Sep
pubmed:issn	1473-6586
pubmed:author	pubmed-author:MessingEdward MEM, pubmed-author:NoyesKatiaK, pubmed-author:SingerEric AEA
pubmed:issnType	Electronic
pubmed:volume	18
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	533-9
pubmed:meshHeading	pubmed-meshheading:18670280-Cost-Benefit Analysis, pubmed-meshheading:18670280-Health Care Costs, pubmed-meshheading:18670280-Humans, pubmed-meshheading:18670280-Urinary Bladder Neoplasms
pubmed:year	2008
pubmed:articleTitle	Healthcare economics of bladder cancer: cost-enhancing and cost-reducing factors.
pubmed:affiliation	Department of Community and Preventive Medicine, University of Rochester School of Medicine and Dentistry, Rochester, New York, USA.
pubmed:publicationType	Journal Article, Review, Research Support, N.I.H., Extramural